"...Surgical oncologists will come together from say head & neck, from breast, GYN... and what we try to understand is ‘do we have shared experiences?’ as were trying to move clinical trials forward for the individual disease sites"-Dr. Lai
@MDAndersonNews
Today is Marie Curie's birthday. She was the first woman to win a Nobel Prize, the only woman to win 2 Nobel Prizes & whose groundbreaking research led to the development of
#radiotherapy
. We celebrate Marie & all the amazing women working in radiation oncology.
#WomenWhoCurie
It is with great sadness we share the passing of Bernard Fisher, MD. He was a Distinguished Service Professor of Surgery at University of Pittsburgh, founding member & past chairman of the NSABP. His research changed & improved the standard of care for women with
#breastcancer
.
We are pleased to announce that Quynh-Thu Le, MD,
@Qle_stanford
, will serve as one of our Group Chairs effective July 1, 2021. She joins Drs. Robert Mannel & Norman Wolmark as the NRG Oncology Group Chairs & principal investigators. Read more:
We are pleased to announce our
#ASTRO21
social media ambassadors! Be sure to follow them during the
@ASTRO_org
meeting next week, Oct 24-27, for their updates about NRG Oncology research being presented, including 2 studies during the plenary session.
#NRGatASTRO21
NRG-HN005 results of scheduled interim futility analysis comparing experimental arm to control arm for randomized phase II portion of the study showed that the experimental arm didn't achieve non-inferiority threshold per statistical analysis plan.
NRG Oncology has announced the appointment of several new Committee Chairs and Vice Chairs representing various areas of the organization. Please read the full press release here:
Protocol Activation! NRG-CC009 Phase III Trial of Stereotactic Radiosurgery (SRS) vs Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for 10 or Fewer Brain Metastases from Small Cell Lung Cancer. Documents posted on
@TheCTSU
NRG Oncology has appointed Felix Feng, MD of the University of California at San Francisco as Chair of its Genitourinary Cancer Committee. Read the press release:
#GUCancers
Couldn't let the day pass without a shoutout for
#INTERNATIONALDAYOFWOMENINSCIENCE
. During
#NRG2022
this week, we've seen so many interesting presentations by women. This Tweet is for you! 👏♀️
Dr. Robinson is kicking off our
#LungCancer
Committee Meeting on the final morning of
#NRG2021
by discussing the PACIFIC-4/RTOG 3515 trial. Head over to that live session now! (Also a big HBD shout out to our presenter
@SBRT_CR
!! 🥳)
NRG names 3 health equity fellows as a part of their Health Equity Fellowship Program: Dr. Franco, Dr. Kamran, & Dr. Saeed - Read more: - Thank you to
@ASTRO_org
@NSABPFoundation
&
@RTOGFoundation
for their generous donations & involvement in this program
Study Activation! NRG-HN009: Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin every 3 Weeks vs Radiation with Low-Dose Weekly Cisplatin for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head & Neck
@TheCTSU
@harari_paul
@uwsmph
Thank you to everyone who attended
#NRG2020
in Houston. Waiting on confirmation, but heard it was our highest attended meeting. Looking forward to seeing you at
#NRG2020
in Washington DC in July!
We are pleased to announce our
#NRG2022
Social Media Workshop! The theme "Paradigm Shifts in Oncology: Social Media & Advocacy." We have an exciting panel of speakers! This session is being chaired by
@MKnoll_MD
& will be held on Monday/Feb 7. Check out our website for more info.
PRESS RELEASE: NRG Oncology NRG-GY018 Study Demonstrates Significantly Improved Progression-Free Survival Outcomes for Women with Advanced or Recurrent
#EndometrialCancer
with the Addition of Pembrolizumab to
#Chemotherapy
- Read more:
The Addition of Stereotactic Body Radiation Therapy (SBRT) to Sorafenib in Patients with Advanced Hepatocellular Carcinoma Improves OS
@ldawsonmd
is live @ the
#ASTRO22
press conference - More at the Plenary Session: 1:30pm CT today
#NRGatASTRO22
Dr. Wally Curran, our good friend & NRG Oncology Group Chair colleague, will step down from his role as NRG Oncology Presiding Group Chair. THANK YOU to Wally for all of his tremendous work on behalf of NRG Oncology! Read more:
PROTOCOL ACTIVATION: NRG-BN012: A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases. Documents are posted on
@TheCTSU
website.
@stuxrt
@StanfordRadOnc
@AtriumHealth
@LevineCancer
September is
#WomenInMedicineMonth
, which recognizes the contributions of women in the medical field. Thank you for all that you do to care for patients, further advancements in
#cancerresearch
and much more!
We are excited to see what our
#ASTRO21
social media ambassadors are going to share about
#NRGatASTRO21
research during the meeting. Be sure to follow them!
Today, we celebrate International Women in Science Day. Thank you to the wonderful researchers and patients who strengthen NRG Oncology’s network and allow us to conduct clinical trials to help those affected by cancer.
#February11
#WomeninScienceDay
#WomeninScience
The NCI National Cancer Act 50th Anniversary Commemoration year is coming to an end this month. Today, we join the entire cancer community by sharing our thoughts about the future of cancer research. Here is
@TGeorgeMD
on what ending cancer means to him.
#NothingWillStopUs
Study Activation NRG-GU011: A Phase II Double-Blinded, Placebo Controlled Trial of Prostate Oligometastatic Radiotherapy with or without Androgen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG PROMETHEAN)
PRESS RELEASE: NRG Oncology Announces New Leadership of Three Committees - We're excited to announce new leadership roles in our Genitourinary Cancer Committee, Radiation Oncology Committee, and DT GYN Phase 1 Subcommittee. Read more:
Please join us today at noon ET for our
#NRG2022
Social Media Workshop and learn about the role of social media in advocacy for oncology! To read more and to register, click here:
Recently activated: NRG-CC009 is a phase III
#clinicaltrial
that will compare SRS to HA-WBRT + memantine for patients with 10 or fewer brain mets from their
#SCLC
. Read more about this study:
Did you know that February 3rd is
#NationalWomenPhysiciansDay
? We have wonderful women physicians involved with NRG who are committed to our research and more importantly, improving the lives of people with cancer. Thank you to all women who make a daily contribution to science!
If you are not going to be at
#ASCO19
, you will feel like you are there by following
@ASCO
's featured voices on social media, including our very own Comms Cmt members
@DrMarkham
&
@MKnoll_MD
!
New Prostate Cancer Study Testing Higher-intensity Treatment for Patients with Higher Gene Risk Scores and Lower-intensity Treatment for Patients with Lower Gene Risk Scores (NRG-GU010, the GUIDANCE trial)
PRESS RELEASE: NRG Oncology Trial Data Concludes Paclitaxel and Carboplatin Should be Considered the Standard of Care as First-line Treatment for Women with Uterine Carcinosarcoma
@WUSTL
#GYN
#gyncsm
#uterinecancer
PRESS RELEASE: The Addition of Gemcitabine with Cisplatin and Intensity-Modulated Radiation Therapy Improves Outcomes for Women with Locally Advanced
#VulvarCancer
- Read the release:
@DanaFarber
#NRGatSGO
Two members of the NRG Oncology Communications Committee are
#ASCO20
Featured Voices - follow them as they share updates from
@ASCO
's virtual meeting later this week!
@DrMarkham
@MKnoll_MD
PRESS RELEASE: Addition of EBRT to
#Brachytherapy
Did Not Improve Outcomes for Men with Intermediate-Risk
#ProstateCancer
, Brachytherapy Alone Remains Standard of Care
NRG Press Release:
JCO Article:
Our Virtual
#SocialMedia
Workshop, chaired by Dr. Knoll, a member of the NRG Communications Cmt, is being held next week. To register for this free, open session, being offered as part of our
#NRG2021
Extended Mtg schedule, click here:
Dr. Christina Henson, an NRG Early Career New Investigator Committee member and
@OUHealth
Radiation Oncologist recently provided her perspective on what it's like being a Study Champion. This was featured in the May NRG Newsletter:
Did you attend any of the
#NRG2020
sessions over the last few days? If so, likely one of these folks helped plan or were running things behind the scenes. Shout-out to our NRG staff, esp
@KatiStoermer
who are true Meeting Champions! (Note: not all Meeting Champion staff pictured)
Congratulations to Dr. Reshma Jagsi
@reshmajagsi
for receiving the 2021 American Medical Women's Association Women in Science Award for her many contributions to the cancer research community. Read more:
Congratulations to
@DeborahWBruner1
, NRG Oncology NCORP Contact PI, for being the recipient of the Penn Nursing 16th Claire M. Fagin Distinguished Researcher Award. The award will be presented virtually to Dr. Bruner tomorrow, April 15. Read more:
In an article published in Forbes,
@MKnoll_MD
writes about the importance of oncologists embracing the age of social media to increase patient awareness of and participation in
#clinicaltrials
.
Effective immediately, NRG-BR002 is permanently closed to accrual. The full phase IIR primary endpoint analysis is complete & the results will be presented at
#ASCO22
by
@Docace911
. Read more:
Over 1,400 people have registered for the
#NRG2020
General Session on Fri/July 17. Our NRG Group chairs, Drs
@wallyjc
, Mannel & Wolmark, will welcome leadership updates on current Research, SDMC, NCORP, Biobanks, Membership & Pubs/Communications.
PROTOCOL ACTIVATION NRG-HN006: Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy Versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer. Documents are posted to the
@TheCTSU
website.
ASCO
#GU22
starts today! Be sure to watch these 2 oral presentations on NRG Research during the Optimizing Management of Localized Prostate Cancer AI, Active Surveillance and Intervention session.
@ASCO
The National Cancer Institute (NCI) has awarded NRG Oncology over $95 Million to support our work over the next six years as a lead protocol organization program in NCI’s National Clinical Trials Network.
A message from our Group Chairs:
#WeAreNRG
As if we needed something else to be excited about at
#NRG2024
! The brand new initiative The NRG Podcast will launch during the NRG Meeting this July with co-hosts
@StephenChunMD
and
@lauren_henke
! Stay tuned for more updates as they become available.
An oral presentation about NRG-BR002 which tested whether treating
#breastcancer
metastases with surgery or high-dose radiation improves survival, will be discussed today by Dr. Steven Chmura
@Docace911
@UCCancerCenter
during the Breast Cancer-Metastatic session at
#ASCO22
.
PRESS RELEASE FROM
#ASTRO22
PLENARY: The Addition of Stereotactic Body Radiation Therapy (SBRT) to Sorafenib in Patients with Advanced Hepatocellular Carcinoma Improves OS
#NRGatASTRO
@ldawsonmd
@pmcancercentre
Our sincerest thank yous to Dr. Machtay for his generous gift of a travel award for a new investigator to attend future NRG Meetings each year
#NRG2020
That's a wrap on our first Virtual Meeting
#NRG2020
! A sincere thank you to everyone who helped plan, presented, sponsored, & attended – we are so grateful and we hope you know that YOU helped make the meeting a success. Until next time! Stay safe & be well!
PRESS RELEASE: NRG Oncology Trial shows that standard of care chemoradiation for Stage III non-small cell lung cancer is superior to two tested alternatives
#lungcancer
The PREDICT-RT study is for patients with HIGH RISK
#prostatecancer
now has a patient study webpage available! Share this with family, friends, or your patients who may be eligible. Check back for more updates as we have them.
@DrPaulNguyen
There's still time to register for our
#NRG2021
#SocialMedia
Workshop, chaired by Dr. Mimi Knoll, that is being held Wed/Feb 3, 1pm ET. To register for this free, open session
#NRG2021
, click here:
@NarjustDumaMD
The National Cancer Act 50th Anniversary Commemoration year is coming to an end. Today, we join the entire cancer community by sharing our thoughts about the future of cancer research.
@Qle_stanford
discusses what ending cancer means to her.
#NothingWillStopUs
That's a wrap in Orlando! THANK YOU to
#NRG2023
attendees, presenters, vendors, sponsors/exhibitors, and social media ambassadors! Safe travels back home to all! We hope to see everyone again for our Summer
#NRG2023
meeting in July in Philadelphia!
Shout-out to our
#ASCO21
social media ambassadors! They did a great job posting about NRG research that was presented during the meeting. We would like to take this opportunity to thank them for their efforts and sharing their insights on our behalf!
The NCI National Cancer Act 50th Anniversary Commemoration year is coming to an end. Today, we join the entire cancer community by sharing our thoughts about the future of cancer research. Here,
@KHigginsMD
explains what ending cancer means to her.
#NothingWillStopUs
The NRG-LU007
#RAPTORtrial
is now open for patient enrollment. This study will test the addition of RT to the usual immune therapy treatment (atezolizumab) for pts with extensive stage small cell lung cancer ES-SCLC. Documents are posted on
@TheCTSU
@MDAndersonNews
@QuynhNguyenMD
The NRG-LU007
#RAPTORtrial
was activated yesterday. This Phase II/III study will test the addition of RT to the usual immune therapy treatment (atezolizumab) for patients with extensive stage small cell lung cancer ES-SCLC. Documents are posted on
@TheCTSU
.
@MDAndersonNews